PDSB

PDS Biotechnology Corp PDSB

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$6.78M total
VANGUARD CAPITAL MANAGEMENT LLC
$1.50M+4.2%
Focus Partners Wealth
$565.8KNew
Quantinno Capital Management LP
$565.8KNew
BlackRock, Inc.
$535.4K+9.7%
GEODE CAPITAL MANAGEMENT, LLC
$517.4K-11.1%
VANGUARD FIDUCIARY TRUST CO
$314.6K+16.2%
Militia Capital Management LLC
$292.3KNew
CITADEL ADVISORS LLC
$285.3KNew
MORGAN STANLEY
$276.6K+7904.1%
BLAIR WILLIAM & CO/IL
$264.3K0.0%
JANE STREET GROUP, LLC
$246.4KNew
RENAISSANCE TECHNOLOGIES LLC
$222.2K+14.2%
INSPIRION WEALTH ADVISORS, LLC
$165.2K+3.8%
MARSHALL WACE, LLP
$129.5KNew
STATE STREET CORP
$117.5K0.0%
NORTHERN TRUST CORP
$111.5K+16.2%
WELLS FARGO & COMPANY/MN
$96.0K-1.4%
COMMONWEALTH EQUITY SERVICES, LLC
$81.9K+2.4%
Iron Gate Global Advisors LLC
$62.0K-6.2%
Bank of New York Mellon Corp
$60.3K-1.2%
Tempus Wealth Planning, LLC
$54.5K0.0%
TWO SIGMA SECURITIES, LLC
$36.5K+31.5%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$32.0K+64.7%
RAYMOND JAMES FINANCIAL INC
$29.8K+230.4%
XTX Topco Ltd
$29.2K-8.6%
See all 52 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/PDSB

Earnings Per Share

13fpro.ai/company/PDSB

Loading ratio trend…

PDSB insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About PDS Biotechnology Corp (PDSB): stock profile, AI score and financials

PDS Biotechnology Corp (PDSB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. PDSB is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of PDSB by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, Focus Partners Wealth, Quantinno Capital Management, based on the most recent SEC filings. PDSB trades on the Nasdaq exchange and files with the SEC under CIK 1472091. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PDSB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for PDS Biotechnology Corp directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1472091 →